CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 34 enrolled
Drug / intervention
Nicotine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03091699
NCT03091699Phase 3Completed
CompareCT.gov

The Acute Effects of Moderate Intensity Exercise and Nicotine on Cognition in Smokers

Western University, Canada·interventional·Posted Mar 27, 2017·Updated May 3, 2024

In Brief

A Phase 3 clinical trial evaluating Nicotine and Moderate Intensity Exercise for Smoking Cessation. Completed, enrolled 34 participants across 1 site.

Detailed Summary

Adult smokers will participate in a two stage testing trial, where the first stage will utilize a within-subject counterbalance design and individuals will participate in both conditions. The second stage will utilize a two-arm randomized control trail. The two conditions are (a) moderate intensity exercise and (b) nicotine inhalation. The primary measure of assessment will be reaction time and accuracy on the N-back task.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesCanada
Collaborators--

Timeline

Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedMar 27, 2017
Enrollment StartMay 1, 2017
Primary CompletionApr 1, 2018
Study CompletionMay 1, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 9.3 years ago

Interventions

Nicotinedrug

Participants will be required to smoke a cigarette to completion in a 20 minute time frame.

Moderate Intensity Exercisebehavioral

Participants will be required to perform 20 minutes of acute moderate intensity exercise (brisk walk) on a treadmill.